On July 9, a delegation including Deng Xijin, Director of the Pharmaceutical Policy Division of the Guangzhou Municipal Health Commission; Su Shiying, First-Class Section Chief; and Lin Wei, Deputy General Manager of Guangdong Yinling Health Industry Co., Ltd., visited the Guangzhou National Laboratory. Wang Huisheng, Assistant Director of the Guangzhou Laboratory; Liang Ping, Director of the Achievement Transformation Department of the Guangzhou Laboratory; and relevant staff from the department, including Wang Dan and Ruan Bibo, attended the meeting. Important consensus was reached on the Guangzhou Laboratory’s participation in the 2025 Guangzhou Medical and Health Industry Expo.
The meeting focused on three core topics:
Deng Xijin, Director of the Pharmaceutical Policy Division of the Guangzhou Municipal Health Commission, pointed out that the participation of the Guangzhou Laboratory will significantly enhance the scientific and technological content and innovative value of the medical expo. "We will fully build a transformation platform to promote precise alignment between the laboratory’s achievements and clinical needs."
Lin Wei, from the Guangzhou Medical Expo Organizing Committee, stated, "We look forward to in-depth cooperation with the national-level scientific research platform, which will help create a more influential industry event and inject new momentum into the high-quality development of the medical and health industry in the Greater Bay Area."
Technology leads industrial transformation, and innovation drives future development. With the heavyweight participation of the Guangzhou Laboratory, the 2025 Guangzhou Medical Expo, to be held from August 22 to 24, is bound to become a benchmark event leading industry innovation. Let us jointly look forward to this wonderful integration of technology and industry!
相关推荐